Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at a new blood test to help diagnose cancer earlier (SYMPLIFY)

Overview

Cancer types:

Anal cancer, Bile duct cancer, Biliary tree cancers, Bowel (colorectal) cancer, Cervical cancer, Gallbladder cancer, Liver cancer, Lung cancer, Oesophageal cancer, Ovarian cancer, Pancreatic cancer, Small bowel cancer, Stomach cancer, Vaginal cancer, Vulval cancer, Womb (uterine or endometrial) cancer

Status:

Results

Phase:

Other

Details

This study looked at a blood test called a multi cancer early detection (MCED) test. It is also called the Galleri test.

It was for people who were having tests for symptoms that might have been cancer.

The study was open for people to join between July and November 2021. The team published the results in 2023.

Recruitment start: 7 July 2021

Recruitment end: 30 November 2021

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Mark Middleton

Supported by

University of Oxford (sponsor)

GRAIL Bio UK Ltd

NHS England

NHS Wales

National Institute for Health Research (NIHR)

Last reviewed: 9 October 2023

CRUK internal database number: 17641

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.